![Vaxart, Inc. logo](/logos/VXRT.webp)
Vaxart, Inc.
NASDAQ:VXRT
Overview | Financials
Company Name | Vaxart, Inc. |
Symbol | VXRT |
Currency | USD |
Price | 0.885 |
Market Cap | 201,329,003 |
Dividend Yield | 0% |
52-week-range | 0.52 - 1.54 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Cezar Andrei Floroiu M.B.A. |
Website | https://vaxart.com |
An error occurred while fetching data.
About Vaxart, Inc.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD